Leveraging its PharmaPatch™ experience, the Company is introducing PatchPrint™ to support existing microneedle patch programs and expand into on-demand personalized patch solutions, including peptide ...

A small patch, no larger than a bandage, may soon change how doctors understand the immune system. Instead of relying on blood draws or surgical biopsies, scientists have created a device that listens ...

Add Yahoo as a preferred source to see more of our stories on Google. Sasan Jalili holds the microneedle skin patch, which is about the size of a quarter. (CREDIT: The Jackson Laboratory) A small ...

This surge is driven by national immunization programs transitioning from cold-chain-dependent liquid vials and syringes to thermostable, self-administrable solid-dose transdermal platforms. NEWARK, ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ...

A couple of decades ago, GLP-1 drugs were a specialised treatment for type-2 diabetes but, fast-forward to today, and they have become much more widespread, being sold to help people with obesity and ...

The GLP-1 weight loss drugs revolutionizing the treatment of obesity, diabetes and a slew of other diseases come with a major caveat: They don’t work for everyone. Some people experience profound ...

"The Girls Next Door" star Kendra Wilkinson is the latest celebrity to open up about taking a GLP drug. The reality TV personality, 40, revealed to US Weekly on Tuesday, March 24, that she will start ...

The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a rapidly growing arsenal of obesity therapies. The orforglipron pill, called ...

GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound are FDA-approved for diabetes and weight loss, but growing evidence suggests their effects may extend beyond blood sugar and body fat, ...